SNX17 protects the heart from doxorubicin-induced cardiotoxicity by modulating LMOD2 degradation.
Zhang Y, Ni L, Lin B, Hu L, Lin Z, Yang J, Wang J, Ma H, Liu Y, Yang J, Lin J, Xu L, Wu L, Shi D.
Zhang Y, et al. Among authors: hu l.
Pharmacol Res. 2021 Jul;169:105642. doi: 10.1016/j.phrs.2021.105642. Epub 2021 Apr 30.
Pharmacol Res. 2021.
PMID: 33933636